Acoltremon ophthalmic solution effectively increases tear production for dry eye disease, demonstrating benefits and a favorable safety profile in clinical trials.
Cassandra R. Doyno, PharmD, BCPS
Advertisement
Articles by Cassandra R. Doyno, PharmD, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5